Benzinga | Nov 2, 2021 04:17PM EDT

Macrogenics Q3 EPS $(0.86) Misses $(0.69) Estimate, Sales $15.70M Down From $18.25M YoY

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.69) by 24.64 percent. This is a 30.3 percent decrease over losses of $(0.66) per share from the same period last year. The company reported $15.70 million in sales this quarter. This is a 13.99 percent decrease over sales of $18.25 million the same period last year.